⚙️ Technology
PCSK9
🧬 AI profile — grown from 6ic coverage
PCSK9, or Proprotein Convertase Subtilisin/Kexin Type 9, is a protein involved in the regulation of cholesterol levels in the blood. It plays a key role in the liver's ability to remove low-density lipoprotein (LDL) cholesterol, also known as "bad" cholesterol, from the bloodstream. The development of PCSK9 inhibitors has led to breakthroughs in cholesterol treatment, offering an alternative to statins for patients with high cholesterol.
Coverage by desk
Health
1
Coverage · last 14 days
Jul 4Jul 17
Recurring themes
🕸 Connection map 🌌 Full galaxy →
Connected entities
Every story (1)
Breakthrough in Cholesterol Treatment: FDA Approves New Alternative to Statins
Health · Jul 17, 2026 · Legacy Media Killer AI